Total Payments
$10,348
2024 Payments
$859.20
Companies
33
Transactions
669
Medicare Patients
2,993
Medicare Billing
$268,438
Payment Breakdown by Category
Food & Beverage$10,348 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,348 | 669 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,428 | 185 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,374 | 81 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,150 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,087 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $602.06 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $571.90 | 36 | $0 (2023) |
| PFIZER INC. | $468.57 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $387.48 | 33 | $0 (2024) |
| Allergan, Inc. | $254.18 | 13 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $250.00 | 18 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $859.20 | 46 | Lilly USA, LLC ($249.48) |
| 2023 | $1,124 | 63 | Novo Nordisk Inc ($272.15) |
| 2022 | $947.64 | 53 | Novo Nordisk Inc ($255.91) |
| 2021 | $1,365 | 78 | Novo Nordisk Inc ($376.37) |
| 2020 | $1,403 | 91 | Novo Nordisk Inc ($306.82) |
| 2019 | $1,389 | 99 | Novo Nordisk Inc ($365.86) |
| 2018 | $1,609 | 115 | Novo Nordisk Inc ($413.92) |
| 2017 | $1,652 | 124 | Novo Nordisk Inc ($385.16) |
All Payment Transactions
669 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.33 | General |
| 11/06/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: VACCINE | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: VACCINE | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.54 | General |
| 07/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: DIABETES | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Oncology | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 746 | 908 | $159,811 | $78,914 |
| 2022 | 10 | 663 | 802 | $133,863 | $60,605 |
| 2021 | 12 | 751 | 899 | $138,538 | $67,307 |
| 2020 | 12 | 833 | 988 | $130,869 | $61,613 |
Total Patients
2,993
Total Services
3,597
Medicare Billing
$268,438
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 274 | $57,540 | $20,759 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 138 | 138 | $32,430 | $18,405 | 56.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 55 | 55 | $19,250 | $15,544 | 80.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 150 | $26,250 | $8,451 | 32.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 72 | 72 | $7,080 | $4,838 | 68.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $5,200 | $2,970 | 57.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 81 | $2,835 | $2,596 | 91.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $3,150 | $1,899 | 60.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 58 | 58 | $2,030 | $1,859 | 91.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 22 | $1,826 | $948.18 | 51.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 17 | $1,870 | $613.66 | 32.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 14 | $350.00 | $30.80 | 8.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 154 | 154 | $36,190 | $21,084 | 58.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 257 | $53,970 | $19,024 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 129 | $22,575 | $7,601 | 33.7% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 79 | 82 | $8,200 | $5,607 | 68.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 78 | 81 | $2,835 | $2,519 | 88.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $3,950 | $2,077 | 52.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 31 | $3,410 | $1,132 | 33.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 18 | 21 | $1,743 | $935.99 | 53.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $665.00 | $594.40 | 89.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 13 | $325.00 | $28.87 | 8.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 165 | 165 | $37,611 | $23,130 | 61.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 177 | 263 | $55,230 | $22,044 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 147 | $20,670 | $8,497 | 41.1% |
About Dr. Inna Milgram, MD
Dr. Inna Milgram, MD is a Internal Medicine healthcare provider based in Villa Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932197597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Inna Milgram, MD has received a total of $10,348 in payments from pharmaceutical and medical device companies, with $859.20 received in 2024. These payments were reported across 669 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($10,348).
As a Medicare-enrolled provider, Milgram has provided services to 2,993 Medicare beneficiaries, totaling 3,597 services with total Medicare billing of $268,438. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Villa Park, IL
- Active Since 10/07/2005
- Last Updated 12/20/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932197597
Products in Payments
- Ozempic (Drug) $1,157
- TRULICITY (Drug) $687.23
- FARXIGA (Drug) $623.60
- XARELTO (Drug) $591.04
- TRADJENTA (Drug) $587.76
- Victoza (Drug) $548.32
- JARDIANCE (Drug) $485.19
- STIOLTO RESPIMAT (Drug) $339.38
- TRELEGY ELLIPTA (Drug) $325.53
- SYMBICORT (Drug) $296.23
- JANUVIA (Drug) $264.40
- Rybelsus (Drug) $259.88
- MOUNJARO (Drug) $224.76
- ELIQUIS (Drug) $166.96
- TOUJEO (Drug) $159.43
- PREVNAR 13 (Biological) $155.53
- QULIPTA (Drug) $140.63
- Tresiba (Drug) $127.50
- ENTRESTO (Drug) $116.52
- Livalo (Drug) $110.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.